Newswise — DETROIT - Benjamin Movsas, M.D., FASTRO, chair of the Department of Radiation Oncology at Henry Ford Cancer Institute, has been elected to serve as Education Council Vice-chair on the American Society for Radiation Oncology (ASTRO) Board of Directors.

ASTRO is a prestigious cancer organization with more than 10,000 members worldwide who specialize in treating patients with radiation therapy.

In his new Board role, Dr. Movsas will steer efforts to provide high-quality, forward-thinking education for ASTRO members. He will begin his term during ASTRO's 60th Annual Meeting in San Antonio this October.

Dr. Movsas has been instrumental in efforts to enhance education and research in radiation oncology and is President of ASTRO's Society of Chairs of Academic Radiation Oncology Programs (SCAROP), and previous Chair of the standing committees for education and science at the ASTRO Annual Meeting.

The members of ASTRO elected Dr. Movsas, along with three new officers to ASTRO's Board of Directors, and four members to serve on the medical society's Nominating Committee.

"Radiation oncology has a central role in discussions on safeguarding cancer patients' access to high-quality, high-value treatments. The dedicated leaders chosen by ASTRO's 10,000-plus members will help drive these conversations and guide our field on the key issues of education, advocacy, quality and safety," said Board of Directors Chair Brian Kavanagh, M.D., MPH, FASTRO.

Dr. Movsas is a recognized leader in radiation oncology, stereotactic radiation, lung cancer, prostate cancer, and quality of life issues pertaining to cancer. He was recently elected President-Elect this summer of the American Radium Society (ARS); he assumes the role of ARS President in Spring 2019.

Dr. Movsas was presented in 2012 with the designation of Fellow of the American Society for Radiation Oncology (FASTRO), one of the most prestigious honors that ASTRO offers.

He also serves as co-chair of the NCI Patient Centered Outcomes Research (PCOR) committee for the NRG clinical trial cooperative group. He has published extensively on the topic of radiation therapy for cancer in many prestigious medical journals and regularly presents his research findings at some of the nation's top medical meetings.

Ranked as one of American's top cancer doctors, Dr. Movsas has been featured in Consumer's Guide to Top Doctors, HOUR Detroit's Top Docs, and the Castle Connolly's America's Top Doctors for Cancer.  He also is a Fellow of both the American Society of Radiation Oncology (ASTRO) and of the American College of Radiology (ACR).

Dr. Movsas received his undergraduate degree from Harvard University and his medical degree from the Washington University School of Medicine.  

For more information about the Henry Ford Cancer Institute's Department of Radiation Oncology, visit

About the Henry Ford Cancer Institute

The Henry Ford Cancer Institute is one of the largest cancer programs in Michigan, providing care at five hospitals and six outpatient facilities, and dozens of aligned doctor's offices throughout southeast and southcentral Michigan. Treatment for the most complex or rare cancers and the Institute's extensive cancer research program is anchored by Henry Ford Hospital. For more information, visit


The American Society for Radiation Oncology (ASTRO) is the world's largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute. To learn more about ASTRO, visit or

Register for reporter access to contact details